News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

PHARMAC decision impacts heavily

Chief Reporter Scoop

AGE CONCERN MEDIA RELEASE -- 14 NOVEMBER 2001

** PHARMAC decision impacts heavily **

A good quality of life for older people with Alzheimer' disease is being denied by PHARMAC's refusal to subsidise new medications. Cost savings in residential and hospital care that could result appear to have been ignored.

"Having recently attended the Alzheimer's Disease International conference, our eyes have been opened to the level of help and relief that is available to many people, through the use of a managed care programme with Alzheimer's medications," says Garth Taylor, Chief Executive, Age Concern New Zealand.

PHARMAC NZ has given a low priority rating to subsidise medications that have been proven to help Alzheimer's' sufferers in a significant number of cases. As the condition progresses, residential and hospital care become inevitable. Any delay in admission to care facilities would result in significant cost savings to the Government and taxpayers.

"This response effectively denies treatment to thousands of New Zealanders with this condition," says Mr Taylor. "What is particularly distressing is that New Zealand stands out as one of a few developed countries where Alzheimer's drugs are not reimbursed by the Government or private health plans. Our 'cousins' in Australia and the UK are able to access them freely, and one must question why PHARMAC chooses to ignore evidence that other countries pharmaceutical agencies have accepted. Is it a case of ignoring the rights of the older members of our community?

"As an advocate for older people, Age Concern is particularly disturbed that many New Zealanders will be denied their dignity and will suffer as a consequence of this decision. It not only affects the sufferer but also their carer and family. It seems that if you are well off and can afford to pay for these medications then you are able to access treatment, but for the ordinary New Zealander this is denied because of the cost.

"We are concerned this PHARMAC decision is indicative of a much wider issue - that there appears to be no provision for the funding of new and progressive drugs that may become available to treat conditions that mainly affect the older population."

ENDS

For further information please contact:

Garth Taylor, Chief Executive (wk) 0-4-471 2709 or (mobile) 025 243 6991

http://www.ageconcern.org.nz

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

City Of 100 Lovers: Multi-Million Dollar NZ Theatre Production To Launch

Produced in New Zealand, the $8Million budget, musical comedy, City of 100 Lovers, has been created for locals and tourists alike. More>>

Indycars: Dixon Wins Fifth US Championship

The New Zealand motor racing driver Scott Dixon has won the US Indycar championship for the fifth time. Dixon finished second in the final race of the season in Sonoma in California. More>>

ALSO:

Howard Davis Review: The Outsider Art of Tony Fomison

Among such gifted contemporaries as Bill Hammond, Tony de la Tour, and printmaker Jason Grieg, Fomison distinguished himself as highly idiosyncratic, and could have become wealthy, had not his demons prevented him from investing his income wisely. In his near monochrome oil painting on black hessian, he staked out a territory of morbid originality. More>>

Scoop Review Of Books: Immortal Love

The series has a wild-west tone with a steampunk vibe, so if you’re a fan of Joss Whedon’s Firefly or Joe Abercrombie’s Shattered Sea, then chances are you’ll enjoy this book. More>>

Howard Davis Review: The Trappings of Success - McQueen

This troubling documentary about the extraordinary life and untimely death of British fashion designer Alexander McQueen (1969 - 2010) is a cautionary tale of an extremely gifted, but self-destructive soul caught up in a business that chews up and spits out its creative talent. More>>

Anne Russell: On Nanette, And The Limitations Of Stories

Since many detractors fault Gadsby or other women for talking about their trauma publicly, Gadsby’s most ardent fans mistakenly perceive virtually any criticism of Nanette as misogynist. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland